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Long-term treatment regimens have been found to retard, but
not completely abrogate, the progression of type 2 diabetes
mellitus.1-3 The disease is characterised by progressive beta-cell
dysfunction and a loss of endocrine mass from the pancreas.4
New therapies are therefore required to stem this islet
depletion and restore pancreatic function. One such therapy
might be to stimulate the formation of new islets (neogenesis)5,6
within the adult pancreas. This would also be of use in the
treatment of type 1 diabetes, where autoimmune reactions have
destroyed beta cells. Understanding the mechanism by which
the pancreas can be stimulated to increase endocrine mass is
therefore of paramount importance in the search for new
therapies.
Beta cells have a very low proliferative index in quiescent
pancreas.7 Although it was once believed that beta cells could
not proliferate, it is now recognised that beta-cell mass can
increase in normal individuals in response to hyperglycaemia,
allowing for more efficient insulin production.8,9 This promotes
homeostasis and facilitates euglycaemia. However, in patients
with type 2 diabetes this compensation mechanism is faulty
and results in a permanent loss of islet mass.10
An increase in islet mass can be promoted by surgical
manipulation of the pancreas in rodents and non-human
primates.  Partial pancreatectomy (90%),11,12 main duct
ligation13,14 or occlusion of the main pancreatic duct by
wrapping the head of the pancreas with cellophane15 result in
an increase in duct cell proliferation which is followed by
increased endocrine mass. Although these manipulations are
unsuitable for humans, understanding the biochemical signals
that initiate this process in rodents could eventually lead to the
recognition of specific pharmacological targets and the
instigation of therapies to address the problem of beta-cell
depletion that occurs during diabetes in humans.
Partial pancreatectomy and ligation of the main pancreatic
duct lead to acute pancreatitis and therefore signals integral to
the neogenic process are masked by pancreatic damage.
Furthermore, 90% pancreatectomy leaves a small pancreatic
stump, which has insufficient tissue for assaying enzymatic
activity of candidate signalling molecules known to participate
in cellular proliferation. Partial occlusion of the main pancreatic
duct by wrapping the head of the pancreas with cellophane
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Objective. Current models of islet neogenesis either cause
substantial pancreatic damage or continuously stimulate the
pancreas, making these models unsuitable for the study of
early events that occur in the neogenic process. We aimed to
develop a method where the initial events that culminate in
increased pancreatic endocrine mass can be studied.
Design and methods. Ten 12-week-old female Wistar rats were
subjected to a midline laparotomy, the pancreas was isolated
and the main pancreatic duct was occluded for 60 seconds.
The pancreas was released and carefully relocated within the
abdomen. Ten age-, strain- and sex-matched control rats were
subjected to a sham operation. The animals were killed 56
days post occlusion, and the pancreata excised and fixed for
histological analysis. Body, pancreatic and hepatic weights
were noted at termination and serum was taken for analysis.
The endocrine-to-exocrine ratio was calculated and the
number of endocrine cells in each islet from the sectioned
pancreata was counted.
Results. Occlusion of the main pancreatic duct for 60 seconds
results in an increase in endocrine mass by 80% 56 days post
occlusion. This constitutes an increase in endocrine units (1 -
6 cells), and in small (7 - 30 cells), medium (31 - 60 cells) and
large (> 60 cells) islets by 85%, 96%, 95% and 71%
respectively.
Conclusion. Brief occlusion of the main pancreatic duct results
in an increase in pancreatic endocrine mass. An increase in
endocrine units and small islets is indicative of islet
neogenesis. Therefore, owing to the briefness of the
stimulation, this model can therefore be used to study the
initial events that occur during the neogenic process.
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results in continuous stimulation of the pancreas, as the
cellophane is left in place postoperatively until termination and
may lead to secondary signals not involved in the neogenic
process. Therefore these methods of promoting neogenesis are
unsuitable for studying the early events that promote increased
endocrine mass.
We have previously found that briefly occluding the main
pancreatic duct for only 60 seconds elicits a near identical duct
cell proliferative response to cellophane wrapping the
pancreas.16 As cellophane wrapping promotes islet neogenesis
we asked whether occlusion for 60 seconds would also result in
an increase in pancreatic endocrine mass. If so, this stimulus
could be used to examine the early events in the neogenic
process, without the presence of confounding non-neogenic
signals.  Such a model could be used to identify the early
events that occur during islet neogenesis and possibly lead to
new therapies for diabetes in the future.
Materials and methods
Surgical procedure
Ten 12-week-old female Wistar rats (~180 g each in mass) were
anaesthetised using 2% fluothane in oxygen. The animals were
subjected to a midline laparotomy, the pancreas was isolated
and the main pancreatic duct partially occluded by gently
squeezing the head of the pancreas between the investigator’s
forefinger and thumb for 60 seconds. The pancreas was
relocated in the abdomen, the laparotomy wound was closed
and the animals were subjected to postoperative care. The rats
were killed 56 days post occlusion. Pancreata were removed,
fixed in formalin (pH 7.0) and used for morphological analysis.
Serum was also collected for quantitative measurement of
amylase, glucose and insulin. Ten age-, strain- and sex-matched
rats were used as controls.
Tissue preparation and staining
Formalin-fixed pancreata were meticulously trimmed of other
tissue, weighed and embedded in paraffin wax. Sections 
(4 µm) were cut across the whole pancreas and mounted on
glass slides. The tissue sections were then de-waxed in xylene
and rehydrated in serial dilutions of ethanol to water and
stained with haematoxylin and eosin. 
Analysis of pancreatic sections
Each tissue section was analysed without prior knowledge of
any procedure that might have been performed on the rat.
Sequential, non-overlapping fields of the whole tissue section
were used to calculate the proportion of endocrine to exocrine
tissue using a 25-point graticule (Pyser-SGI, UK) (Fig. 1).17 The
number of cells in each islet in the section was also counted.
Serum insulin, glucose and amylase assays
Serum glucose, insulin and amylase were measured at
termination in animals fasted overnight. Amylase levels were
measured using Beckman amylase reagent, glucose with
Technicon glucose (Glu-cinet) reagent and insulin with a Linco
RIA kit.
Statistics
The p-values are for a one-sided t-test for no difference in
means assuming that the variances are not necessarily equal.
Results
Brief occlusion of the main pancreatic duct does not
significantly alter body weight (control = 182 g, occluded = 
180 g, p = 0.747), liver weight (control = 25.5 g, occluded = 
26.1 g, p = 0.630), plasma glucose (control = 3.4 mM, occluded
= 3.5 mM, p = 0.592) or amylase (control = 706 u/l, occluded =
739 u/l, p = 0.694) levels measured at 56 days post occlusion.
Animals subjected to brief occlusion of the main pancreatic
duct appeared healthy, and morphological examination of
pancreatic sections showed no obvious evidence of
pancreatitis. The mean fasting insulin level of animals
subjected to partial occlusion were significantly lower.
However, all individual measurements were still within the
Fig. 1. A 25-point graticule in the eyepiece of a microscope was used
to assess the endocrine-to-exocrine ratio. The number of dots falling
on endocrine and exocrine tissue was noted for each field of view
taken sequentially over the whole pancreatic section.
range of values seen in controls (control = 77.8 pM, occluded = 
39.8 pM, p = 0.038). Further investigation examining another 12
animals subjected to duct occlusion showed no significant
differences between this group and controls (data not shown).
Calculation of the endocrine-to-exocrine ratio revealed that
this is increased by 37.5% in occluded pancreata compared
with controls. Pancreatic weight, compared with body weight,
was also increased by 24.5%. Knowing the pancreatic weight
and endocrine-to-exocrine ratio enables the endocrine mass to
be calculated. This was increased by 80% in occluded pancreata
(Fig. 2).
The number of endocrine cells per islet for each pancreatic
section was counted. Islets were then grouped into four
categories, namely endocrine units (1 - 6 cells), small islets 
(7 - 30 cells), medium islets (31- 60 cells) or large islets (> 60
cells). The mass increased in all islet types, with endocrine
units, small, medium and large islets increased by 85%, 96%,
95% and 71% respectively. 
Discussion
Current mono- and combination therapies for type 2 diabetes
slow the progression of the disease, but do not stem the
associated progressive beta-cell dysfunction and islet loss.1-3
Consequently many patients will eventually require treatment
with insulin regardless of the therapy employed. Alternative
therapies are therefore needed to abrogate beta-cell dysfunction
and islet depletion in type 2 diabetes and replenish lost beta
cells in type 1 diabetes. One such therapy might be the
stimulation of the formation of new islets within the pancreas. 
Surgical manipulation of the pancreas can stimulate an
increase in endocrine mass in rodents11,13-15,18 and non-human
primates.19 Understanding the signals that initiate this process
may lead to new therapeutic approaches which could be used
in the treatment of diabetes in man. Current procedures such as
partial pancreatectomy and total duct ligation result in
substantial organ injury and pancreatitis. Furthermore
cellophane wrapping continuously stimulates the pancreas as
the cellophane remains tied around the head of the organ
postoperatively. Therefore these procedures are unsuitable for
the study of early events that lead to islet neogenesis due to the
possible presence of confounding secondary signals.
Here we have shown that brief occlusion of the main
pancreatic duct for 60 seconds stimulates a substantial increase
in endocrine mass.  As all islet types were increased new islet
formation must have occurred. This increase in endocrine units
and small islets is indicative of islet neogenesis.20,21
Normal serum amylase levels and normal pancreatic
morphology at 56 days post occlusion indicate minimal
pancreatic damage. Animals subjected to duct occlusion were
healthy and glycaemia was unchanged compared with
controls. Fasting insulin levels of occluded animals were all in
the lower third of the range observed for the controls.
Conceivably the lower fasting insulin levels were due to the
inability of beta cells to secrete insulin efficiently while
undergoing cellular proliferation during the neogenic process.
However, as glucose levels were not significantly different
between occluded and control groups, indicating that insulin
levels were sufficient to maintain euglycaemia, a further set of
animals was subjected to ductal occlusion. Insulin levels from
these animals were not significantly different from controls and
also fell within the range of the control group. It was therefore
assumed that the lower mean insulin level found in the group
examined in this paper was not biologically meaningful.
In conclusion, brief occlusion of the main pancreatic duct
stimulates islet neogenesis without detectable organ damage.
This method can therefore be used as a model to study the
early events that stimulate islet neogenesis without the
presence of confounding secondary signals. This may possibly
lead to the identification of new molecular targets and
therapies for the treatment of diabetes.
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occlusion of the main pancreatic duct and controls. Mean body
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Ordinarily, violence and injury inflicted on enemy forces in the
war zone is regarded as normal, but the same cannot be said
when it occurs among members of the same force or allied
forces. Thus homicidal violence inflicted by a soldier on his
fellow soldiers is a grave source of concern.
It has been suggested that the risk of homicide is particularly
high among people with post-traumatic stress disorder
(PTSD).1 Sometimes homicidal violence presents as sudden
explosive rage with little or no warning and may be associated
with substance use or subtle organic cerebral lesion.
Although murder is a well-recognised cause of mortality
among adolescents and young adults,2 and a vast majority of
active military personnel are young, few data are available on
Homicidal violence during foreign military missions —
prevention and legal issues
G T Okulate, C Oguine
Objectives. The study involved Nigerian soldiers engaged in
peacekeeping missions in Liberia and Yugoslavia. Using case
illustrations, the study sought to describe patterns of
homicidal violence among soldiers from the same country or
soldiers from allied forces, and to suggest possible reasons for
the attacks.
Design and setting. Nigeria was actively involved in
peacekeeping missions in Liberia between 1990 and 1996.
During this period, intentional homicidal attacks occurred
among the Nigerian military personnel. Post-homicidal
interviews conducted among the perpetrators were combined
with evidence obtained at military courts to produce the case
studies.
Subjects. Six Nigerian military personnel who attacked other
Nigerians or soldiers from allied forces, with homicidal
intent.
Results. Possible predisposing and precipitating factors for
these attacks were highlighted. The possibility of recognising
these factors before embarking on overseas missions was
discussed, so that preventive measures could be instituted as
far as possible. Finally, medico-legal implications of homicide
in the military were discussed.
Conclusions. A certain degree of pre-combat selection is
essential to exclude soldiers with definite severe
psychopathology. A clearly defined length of duty in the
mission areas and adequate communication with home could
reduce maladjustment. Health personnel deployed to mission
areas should be very conversant with mental health issues so
that early recognition of psychological maladjustment is
possible. 
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